Breaking News
4111 - 4125 of 6634 results
Prev
273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443
Next
May 26, 2009
Amgen has exercised its option to obtain an exclusive worldwide license (excluding Japan) to Cytokinetics Inc.'s cardiac contractility program. The license includes CK-1827452, a cardiac myosin activator being developed for the treatment of heart failure.
Read More »
May 26, 2009
Johnson & Johnson and Cougar Biotechnology, Inc. entered a definitive agreement under which J&J will acquire Cougar Biotechnology for approximately $1.0 billion in cash.
Read More »
May 26, 2009
Jeffrey M. Stamps has been named senior vice president, pharmacy operations, Beth A. Kinerk has been named senior vice president, sales and customer development, and Jonathan D. Borman has been named vice president strategic sourcing, Omnicare, Inc.
Read More »
May 22, 2009
Almac, Pfizer and the PETACC3 Translational Research Working Party (PTRW) will conduct a collaborative study involving gene expression profiling of formalin-fixed paraffin-embedded (FFPE) samples from the Pan-European Trials in Adjuvant Colon Cancer (PETA
Read More »
May 22, 2009
Argenta Discovery and Porsolt have entered into an alliance to provide CNS and pain drug discovery services.
Read More »
May 22, 2009
ACORN CRO has developed a new technology called STAR (Site Tracking And Recruitment) to help speed the site selection process as well as automate the study feasibility process.
Read More »
May 21, 2009
Novartis will acquire Ebewe's injectable oncology business for $1.2 billion, and fold it into its Sandoz generics business.
Read More »
May 21, 2009
Asymchem Laboratories has opened its HPAPI and Drug Product facility in TEDA Tianjin, China.
Read More »
May 21, 2009
Pfizer has entered into generic licensing agreements with two pharmaceutical companies based in India, boosting its position in emerging markets.
Read More »
May 20, 2009
Morphotek and Lonza have executed a manufacturing services agreement to support the development and manufacturing of a subset of antibodies in Morphotek's therapeutic antibody pipeline. The agreement will reserve capacity for commercial manufacturing…
Read More »
May 20, 2009
Two studies provide data for Rituxan's benefits in Progression Free Survival in chronic lymphocytic leukemia.
Read More »
May 19, 2009
Schering-Plough and Novartis have amended their global collaboration for the development and commercialization of fixed-dose combination therapies for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Read More »
May 19, 2009
Patheon has launched cell based assay services to support biopharmaceutical product development.
Read More »
4111 - 4125 of 6634 results
Prev
273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443
Next
